Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Similar articles for PubMed (Select 23662495)

1.

[Modern approaches to the treatment of patients with overactive bladder and urge urinary incontinence].

Razdorskaia MV, Neĭmark AI, Aliev RT.

Urologiia. 2013 Jan-Feb;(1):44-6, 48-9. Russian.

PMID:
23662495
2.

Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.

Nitti VW, Rovner ES, Bavendam T.

BJU Int. 2010 May;105(9):1268-75. doi: 10.1111/j.1464-410X.2009.09037.x. Epub 2009 Nov 4.

PMID:
19889062
3.

Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.

Bach P, Wormland RT, Möhring C, Goepel M.

Neurourol Urodyn. 2009;28(3):209-13. doi: 10.1002/nau.20624.

PMID:
19205067
4.

Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders.

Liu HT, Chen CY, Kuo HC.

J Formos Med Assoc. 2010 Dec;109(12):862-78. doi: 10.1016/S0929-6646(10)60133-7. Review.

PMID:
21195884
5.

Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence.

Panayi DC, Duckett J, Digesu GA, Camarata M, Basu M, Khullar V.

Neurourol Urodyn. 2009;28(1):82-5. doi: 10.1002/nau.20576.

PMID:
19089898
6.

Duloxetine compared with placebo for treating women with symptoms of overactive bladder.

Steers WD, Herschorn S, Kreder KJ, Moore K, Strohbehn K, Yalcin I, Bump RC; Duloxetine OAB Study Group.

BJU Int. 2007 Aug;100(2):337-45. Epub 2007 May 19.

PMID:
17511767
7.

[Treatment of overactive urinary bladder with imperative urinary incontinence in women].

Neĭmark AI, Riapolova MV, Mel'nik MA.

Urologiia. 2010 Mar-Apr;(2):36-8. Russian.

PMID:
20967993
8.

Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity?

Haylen BT, Chetty N, Logan V, Schulz S, Verity L, Law M, Zhou J.

Int Urogynecol J Pelvic Floor Dysfunct. 2007 Feb;18(2):123-8. Epub 2006 Jul 6.

PMID:
16823541
9.

Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.

Rogers RG, Bachmann G, Scarpero H, Jumadilova Z, Sun F, Morrow JD, Guan Z, Bavendam T.

Curr Med Res Opin. 2009 Sep;25(9):2159-65. doi: 10.1185/03007990903103279.

PMID:
19601704
10.

In women with urinary incontinence how necessary is cystometry?

Saleem A.

J Pak Med Assoc. 2010 May;60(5):356-9.

PMID:
20527606
11.

Urodynamic assessment of children treated with botulinum toxin A injections for urge incontinence: a pilot study.

Lahdes-Vasama TT, Anttila A, Wahl E, Taskinen S.

Scand J Urol Nephrol. 2011 Dec;45(6):397-400. doi: 10.3109/00365599.2011.590997. Epub 2011 Jul 8.

PMID:
21740110
12.

Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.

Malone-Lee JG, Al-Buheissi S.

BJU Int. 2009 Apr;103(7):931-7. doi: 10.1111/j.1464-410X.2009.08361.x. Epub 2009 Mar 5.

PMID:
19281469
13.

Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.

DuBeau CE, Morrow JD, Kraus SR, Creanga D, Bavendam T.

Neurourol Urodyn. 2012 Nov;31(8):1258-65. doi: 10.1002/nau.22252. Epub 2012 Aug 20.

PMID:
22907761
14.

[Characteristics of bladder microcirculation in women with overactive bladder].

Neĭmark AI, Neĭmark BA, Klyzhina EA, Batanina IA.

Urologiia. 2010 Nov-Dec;(6):28-30. Russian.

PMID:
21427990
15.

Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence.

Campbell JD, Gries KS, Watanabe JH, Ravelo A, Dmochowski RR, Sullivan SD.

BMC Urol. 2009 Nov 20;9:18. doi: 10.1186/1471-2490-9-18. Review.

16.

Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.

Amarenco G, Ismael SS, Even-Schneider A, Raibaut P, Demaille-Wlodyka S, Parratte B, Kerdraon J.

J Urol. 2003 Jun;169(6):2210-5.

PMID:
12771752
17.
18.
19.

Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment.

Alloussi SH, Lang Ch, Eichel R, Al-Kaabneh A, Seibold J, Schwentner C, Alloussi S.

World J Urol. 2012 Jun;30(3):367-73. doi: 10.1007/s00345-011-0736-6. Epub 2011 Aug 13.

PMID:
21842216
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk